Reporting Manager
Soleus Capital Master Fund, L.P.
Symbol
NVCR
Shares outstanding
110,428,280 shares
Disclosed Ownership
5,521,414 shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
01 Apr 2025, 17:00:03 UTC
Date of event
31 Mar 2025
Next filing
05 Aug 2025

Key filing fact

Soleus Capital Master Fund, L.P. disclosed 5% ownership in NOVOCURE LIMITED Ordinary Shares, no par value per share (NVCR) on 31 Mar 2025.

Key facts

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13G for NOVOCURE LIMITED Ordinary Shares, no par value per share (NVCR).
  • Disclosed ownership: 5%.
  • Date of event: 31 Mar 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 01 Apr 2025, 17:00.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (6)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 5% 5,521,414 0 5,521,414 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 5% 5,521,414 0 5,521,414 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 5% 5,521,414 0 5,521,414 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 5% 5,521,414 0 5,521,414 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 5% 5,521,414 0 5,521,414 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 5% 5,521,414 0 5,521,414 /s/ Guy Levy Guy Levy/Managing Member
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .